IPO registrations (S-1, F-1) · Registrants
DNA Testing Centers Corp
- SEC CIK
- 1620070 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-10-24, last 2015-10-06; 1 initial registration, 6 amendments
- Outcome
- Declared effective 2015-10-07
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances 2835
- Incorporated in
- FL
- Business address
- 2378 PARKHAVEN, Oakville, A6 L6H 0E7
- EDGAR entity type
- operating
- Insiders and CEO pay
- DNA Testing Centers Corp on the corporate pages
Offering terms
- Shares offered
- 584,597 (all by selling holders)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: DNA Testing Centers Corp EXACT (CIK (EXACT))
- SEC filer: DNA TESTING CENTERS CORP EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-10-24 | S-1 | S-1 (registration) | DNA Testing Centers Corp | 0001511164-14-000603 ↗ |
| 2015-01-28 | S-1/A | S-1/A (amendment) | DNA Testing Centers Corp | 0001511164-15-000048 ↗ |
| 2015-04-15 | S-1/A | S-1/A (amendment) | DNA Testing Centers Corp | 0001511164-15-000210 ↗ |
| 2015-05-05 | S-1/A | S-1/A (amendment) | DNA Testing Centers Corp | 0001511164-15-000241 ↗ |
| 2015-07-22 | S-1/A | S-1/A (amendment) | DNA Testing Centers Corp | 0001511164-15-000364 ↗ |
| 2015-09-17 | S-1/A | S-1/A (amendment) | DNA Testing Centers Corp | 0001511164-15-000475 ↗ |
| 2015-10-06 | S-1/A | S-1/A (amendment) | DNA Testing Centers Corp | 0001511164-15-000488 ↗ |
| 2015-10-07 | EFFECT | EFFECT (declared effective) | DNA Testing Centers Corp | 9999999995-15-002672 ↗ |
| 2017-02-06 | EFFECT | EFFECT (declared effective) | DNA Testing Centers Corp | 9999999995-17-000298 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-10-06 | S-1/A | registration statement | $0.15 | 584,597 | $87,689 | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-09-23 | DNA Testing Centers Corp | Other Technology | Indefinite | $91,936 | 21 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | DNA Testing Centers Corp | Form D private offerings | CIK (EXACT) | |
| SEC filer | DNA TESTING CENTERS CORP | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry In Vitro & In Vivo Diagnostic Substances, A6 first:
- Anbio Biotechnology 2M
- Asep Medical Holdings Inc. A1
- NYMOX PHARMACEUTICAL CORP A8
- MABCURE INC. B9
- ANSYS DIAGNOSTICS INC CA
- Monogram Biosciences, Inc. CA
- ARGONAUT TECHNOLOGIES INC CA
- GENENCOR INTERNATIONAL INC CA
- Intuity Medical, Inc. CA
- Global Wholehealth Partners Corp CA
In other datasets, the same topic (Health) in A6:
- Form D issuer: 12632926 Canada Ltd. (Form D private offerings)
Interests: In Vitro & In Vivo Diagnostic Substances · Health